This paper examines processes of translation through which molecular genetic technologies and practices are incorporated into environmental health research and regulation. Specifically, it considers how scientists, risk assessors, and regulators have used genetically modified mouse models to translate across scientific disciplines, articulate emergent molecular forms, standards, and practices with the extant? gold standard,? and establish roles for molecular knowledge in risk assessment and regulation. Noting variation both within and between regulatory agencies in responses to data from these models, the article describes also the role of public-private networks and their effects on professional and institutional imperatives which shape regulators? responses to the potential applications of these models. The conclusions address the importance of translation for understanding the wider implications of the molecularization of environmental health science.
Abir-Am, P.1985. Themes, genres, and orders of legitimation in the consolidation of new scientific disciplines. History of Science23 (59): 73-117.
2.
Adele E. Clarke and Susan Leigh Star .2003. “Symbolic Interactionist Studies of Science, Technology and Medicine.” Pp. 539-574 in Handbook of Symbolic Interactionism, edited by Larry Reynolds and Nancy Herman.Walnut Creek, CA: Alta Mira Press.
3.
———. The biotheoretical gathering, trans-disciplinary authority, and the incipient legitimation of molecular biology in the 1930s: New perspective on the historical sociology of science. History of Science26 (67): 1-69.
4.
Bucher, J.R.1998. Update on National Toxicology Program assays with genetically altered or transgenic mice. Environmental Health Perspectives106 (10): 619-21.
5.
Callon, M.1986. Some elements of a sociology of translation: Domestication of the scallops and fisherman of St. Brieuc Bay. In Power, action, and belief, ed. John Law, 196-229. London: Routledge .
6.
———. 1995. Four models for the dynamics of science. In Handbook of science and technology studies, S. Jasanoff, G. Markle, J. Peterson, and T. Pinch , 29-63. Thousand Oaks, CA: Sage.
7.
Casper, M.1998. The making of the unborn patient: A social anatomy of fetal surgery. New Brunswick, NJ: Rutgers University Press.
8.
Clarke AE1997. A Social Worlds Research Adventure: The Case of Reproductive Science. In Grounded Theory in Practice, eds. Anselm Strauss and Julia Corbin, pp. 63-94. Thousand Oaks, CA: Sage.
9.
Clarke, A.E.1998. Disciplining reproduction: Modernity, American life sciences, and the problems of sex. Berkeley, CA: University of California Press.
10.
Clarke A.E., Mamo L., Fishman J.R., Shim J.K., Fosket J.R.2003. Biomedicalization: Technoscientific Transformations of Health, Illness, and U.S. Biomedicine. American Sociological Review68: 161-94.
11.
De Chaderevian, S., and H. Kamminga, eds. 1998. Molecularizing biology and medicine: New practices and alliances, 1910s-1970s. Amsterdam: Harwood.
12.
Donehower, L.A., M. Harvey, B.L. Slagle, M.J. McArthur, C.A. Montgomery Jr., J.S. Butel, and A. Bradley.1992. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature356 (6366): 215-21.
13.
Dunnick, J., J. Hardisty, R. Herbert, J. Seely, E. Furedi-Machacek, J. Foley, G. Lacks, S. Stasiewicz, and J. French.1997. Phenolphthalein induces thymic lymphomas accompanied by loss of the p53 wild type allele in heterozygous p53 deficient +/— mice. ToxicologicPathology25 (6): 533-40.
14.
Eastin, W.C.1998. The National Toxicology Program evaluation of transgenic mice as predictive models for identifying carcinogens. Environmental Health Perspectives106 (Suppl. 1): 81-84.
15.
Eddy, M.1993. The use of transgenic mice for environmental health research . Environmental Health Perspectives1014101 (4): 298-300.
16.
Emmen, J.M., and K.S. Korach.2001. Developing animal models for analyzing SERM activity. Annals of the New York Academy of Sciences949: 36-43.
Fujimura J.1996. Crafting science: A sociohistory of the quest for the genetics of cancer. Cambridge, MA: Harvard University Press.
19.
Glaser, B.G., and A.L. Strauss.1967. The discovery of grounded theory. Chicago: Aldine.
20.
Gordon, J.W.1989. Transgenic animals. International Review of Cytology115: 171-229.
21.
Gordon, J.W., and F.H. Ruddle.1981. Integration and stable germline transformation of genes injected into mouse pronuclei. Science214 (4526):1244-46.
22.
Harris, C.C.1996. Structure and function of the p53 tumor suppressor gene: Clues for rational cancer therapeutic strategies. Journal of theNational Cancer Institute88 (20): 1442-55.
23.
Hess, D.1997. Science studies: An advanced introduction. New York: New York University Press.
24.
Hollstein, M., D. Sidransky, B. Vogelstein, and C.C. Harris.1991. p53 mutations in human cancers. Science253 (5015): 49-53.
25.
Kay, L.1993. The molecular vision of life: Caltech, the Rockefeller Foundation and the new biology. New York: Oxford University Press.
26.
Kevles, D.J. and G.L. Geison.1995. The Experimental Sciences in the Twentieth Century. Osiris10: 97-121.
27.
Kohler RE1994. Lords of the Fly: Drosophila Genetics and the Experimental Life. Chicago, IL: University of Chicago Press.
28.
Latour, B.1987. Science in action: How to follow scientists and engineers through society. Cambridge, MA: Harvard University Press.
29.
Law, J.1999. After Method: Complexity, Naming, and Topology. Pp. 1-15 in Actor Network Theory and After. (Eds) J. Law and J. Hassard.Oxford: Blackwell/Sociological Review.
30.
Law, J., and J. Hassard, eds. 1999. Actor network theory and after. Oxford, UK: Blackwell/ Sociological Review.
31.
Lowy, I., and J.P. Gaudilliere .1998. Disciplining cancer: Mice and the practice of genetic purity. In The invisible industrialist: Manufacturers and the production of scientific knowledge, ed. I. Lowy and J. P. Gaudilliere , 209-249. London: Palgrave Macmillan.
32.
Medina, D., R. Ullrich, R. Meyn, R. Wiseman, and L. Donehower.2002. Environmental carcinogens and p53 tumor-suppressor gene interactions in a transgenic mouse model for mammary carcinogenesis. Environmental and Molecular Mutagenesis39 (2/3): 178-83.
33.
National Institute of Environmental Health Sciences (NIEHS).1997. A Summary of the Environmental Genome Project Symposium. Presented at Environmental Genome Project Symposium, National Institutes of Health. Bethesda, MD.
34.
National Institute of Environmental Health Sciences (NIEHS).2002. Current directions and evolving strategies . Washington, DC: Department of Health and Human Services.
National Toxicology Program (NTP) Board of Scientific Counselors.1984. Ad Hoc Panel on Chemical Carconigenesis Testing and Evaluation. Research Triangle Park, NC: NIEHS/NTP.
37.
———. Toxicity reports. http://ehp.niehs.nih.gov/ntp/docs/toxreports.html (accessed January 15, 2007).
38.
Palmiter, R.D., and R.L. Brinster.1985. Transgenic mice. Cell41 (2): 343-45.
39.
Pauly, P.J.1987. Controlling life: Jacques Loeb and the engineering ideal in biology. New York: Oxford University Press.
40.
Pritchard JB, French JE, Davis BJ, Haseman JK2003. The role of transgenic mouse models in carcinogen identification . Environmental Health Perspectives111(4):444-54.
41.
Rabinow, P.1992. Artificiality and enlightenment: From to sociobiology biosociality. In Essays on the anthropology of reason, ed. P. Rabinow, 234-52. Princeton, NJ : Princeton University Press.
42.
Rader, K.2004. Making mice: Standardizing animals for American biomedical research, 1900-1955. Princeton, NJ: Princeton University Press.
43.
Robinson, D.E., and J.S. MacDonald.2003. Background and framework for ILSIs collaborative evaluation program on alternative models for carcinogenicity assessment. Toxicologic Pathology29: 13-19.
44.
Rose, N.2001. The politics of life itself. Theory, Culture, and Society18 (6): 1-30.
45.
Schmidt, C.W.2002. Toxicogenomics: An emerging discipline. Environmental Health Perspectives110 (1T): 750-56.
46.
Sellers, C.1997. Hazards of the job: From industrial disease to environmental health science. Chapel Hill: University of North Carolina Press.
47.
Shostak, S.2005. The emergence of toxicogenomics: A case study of molecularization . Social Studies of Science35 (3): 367-403.
48.
Smithies, O., and H.S. Kim.1994. Targeted gene duplication and disruption for analyzing quantitative genetic traits in mice. Proceedings of the National Academy of Science of the United States of America91 (9): 3612-15.
49.
Star, S.L., and J. Griesemer.1989. Institutional ecology, translations, and boundary objects. Social Studies of Science19 (3): 387-420.
50.
Stone, R.1993. Ken Olden Health NIEHS's `Split Brain.' Science259: 1398-1399.
51.
Strauss, A.1978. A Social Worlds Perspective. In Studies in Symbolic Interactionism, I., ed. N Denzin.Greenwich, CT: JAI Press.
52.
Strauss, A.L.1987. Qualitative analysis for social scientists. New York: Cambridge University Press.
53.
———. The articulation of project work: An organizational process. Sociological Quarterly29 (2): 163-78.
54.
Strauss, A.L., and J. Corbin.1990/1998. Basics of qualitative research. Newbury Park, CA: Sage .
55.
Tennant, R.W., J.E. French, and J.W. Spalding.1995. Identifying chemical carcinogens and assessing potential risk in short-term bioassays using transgenic mouse models . Environmental Health Perspectives103 (10): 942-50.
56.
Tennant, R.W., Margolin, B.H., Shelby, M.D., Zeiger E., Haseman, J.K., Spalding, J., Caspary, W., Resnick, M., Stasiewicz, S., Anderson, B.1987. Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicity assays. Science:236 (4804): 933-41.
57.
Timmermans, S., and M. Berg.1997. Standardization in action: Achieving local universality through medical protocols. Social Studies of Science27 (2): 273-305.
58.
———. 2003. The gold standard: The challenge of evidence based medicine and standardization in health care. Philadelphia : Temple University Press.
